Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003227487 | SCV000651968 | uncertain significance | Autosomal dominant centronuclear myopathy | 2018-08-21 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with glutamine at codon 111 of the MYF6 protein (p.Glu111Gln). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is present in population databases (rs773695133, ExAC 0.006%). This variant has not been reported in the literature in individuals with MYF6-related disease. ClinVar contains an entry for this variant (Variation ID: 472753). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |